Document Detail

The safety assessment of nanomaterials in reproductive developmental field.
MedLine Citation:
PMID:  22382838     Owner:  NLM     Status:  In-Data-Review    
A diverse array of nanomaterials (NMs) such as amorphous nanosilica and carbon nanotubes have become widespread in use due to the development of nanotechnology. NMs are already being applied in universal fields because they have unique physicochemical properties. On the other hand, the increasing use of NMs has raised public concern about their potential risks to human health. In particular, recent reports indicated that carbon nanotubes induced mesothelioma-like lesions in mice, in a way similar to those induced by crocidolite asbestos. However, current knowledge of the potential risk of nanomaterials is considered insufficient. Because NMs have the potential to improve the quality of human life, it is essential to ensure the safety of NMs and provide information for designing NMs with safety. Especially, few studies have examined the effect of NMs on maintenance of pregnancy. Similar to the cases of thalidomide, a lot of evidence shows that fetuses are affected more than adults by a variety of environmental toxins because of physiological immaturity. Therefore it is essential to examine the effect of NMs on fetuses and pregnancies. Here we introduce the potential risk of amorphous nanosilica, most widely used NMs in food and the cosmetics field, to induce fetotoxicity and useful information for developing NMs with safety.
Kohei Yamashita; Yasuo Yoshioka
Related Documents :
20493478 - Heavy ion radiotherapy during pregnancy.
12746998 - Superior vena cava syndrome in pregnancy. a case report.
10341408 - Antenatal sonographic diagnosis of epignathus at 15 weeks of pregnancy.
16527708 - Pregnancy after endometrial ablation: english literature review and case report.
3113648 - Prognosis of subsequent pregnancies after recurrent spontaneous abortion in first trime...
20493478 - Heavy ion radiotherapy during pregnancy.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan     Volume:  132     ISSN:  1347-5231     ISO Abbreviation:  Yakugaku Zasshi     Publication Date:  2012  
Date Detail:
Created Date:  2012-03-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0413613     Medline TA:  Yakugaku Zasshi     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  331-5     Citation Subset:  IM    
The Center for Advanced Medical Engineering and Informatics, Osaka University.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  How do transport and metabolism affect on the biological effects of polycyclic aromatic hydrocarbons...
Next Document:  Implementation of "Collaborative Development of Advanced Practical Education Program to Train Pharma...